From the Division of HIV/AIDS Prevention, and.
Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Sex Transm Dis. 2018 Jul;45(7):469-475. doi: 10.1097/OLQ.0000000000000786.
Annual screening for chlamydia and gonorrhea is recommended for sexually active men who have sex with men (MSM) at anatomical sites of contact, regardless of condom use.
We assessed differences in self-reported chlamydia and gonorrhea testing and diagnosis in the past 12 months among MSM using National HIV Behavioral Surveillance data from 2011 and 2014. Men who have sex with men who had 1 or more partners in the past 12 months were included in analyses. Analyses of chlamydia and gonorrhea diagnosis data were limited to participants who reported past 12 months chlamydia and gonorrhea testing, respectively. Differences in testing and diagnosis over time were assessed using Poisson regression models with robust standard errors separately for chlamydia and gonorrhea.
Analyses included data from 18,896 MSM (2011, n = 9256; 2014, n = 9640). Testing for chlamydia was 37% in 2011 and 47% in 2014 (prevalence ratio [PR], 1.25; 95% confidence interval [CI], 1.20-1.30) and 38% and 47% for gonorrhea (PR, 1.24; 95% CI, 1.19-1.29). Testing was higher in 2014 among most demographic subgroups. Prevalence of chlamydia diagnoses was 8% in 2011 and 11% in 2014 (PR, 1.37; 95% CI, 1.18-1.59) and of gonorrhea diagnoses was 10% in 2011 and 14% in 2014 (adjusted PR: 1.40, 95% CI, 1.23-1.60). Larger changes in diagnoses were observed among MSM in the white and "other" racial categories and those who disclosed same-sex behavior to their health care provider.
Self-reported testing and diagnoses among MSM increased from 2011 to 2014. Increased efforts are needed to meet annual sexually transmitted disease screening recommendations among MSM at high HIV risk.
无论是否使用安全套，每年都建议有性接触的男男性行为者（MSM）在接触部位筛查衣原体和淋病。
我们利用 2011 年和 2014 年国家艾滋病毒行为监测数据，评估了 MSM 过去 12 个月中自我报告的衣原体和淋病检测和诊断差异。分析包括过去 12 个月内有 1 个或多个性伴侣的男男性行为者。对衣原体和淋病检测数据的分析仅限于分别报告过去 12 个月内衣原体和淋病检测的参与者。使用泊松回归模型分别评估衣原体和淋病检测和诊断随时间的差异，并使用稳健标准误差进行校正。
分析纳入了 18896 名 MSM（2011 年，n=9256；2014 年，n=9640）。2011 年和 2014 年的衣原体检测率分别为 37%和 47%（患病率比[PR]，1.25；95%置信区间[CI]，1.20-1.30），淋病检测率分别为 38%和 47%（PR，1.24；95% CI，1.19-1.29）。在大多数人口统计学亚组中，2014 年的检测率更高。2011 年和 2014 年的衣原体诊断率分别为 8%和 11%（PR，1.37；95% CI，1.18-1.59），淋病诊断率分别为 10%和 14%（调整后 PR：1.40，95% CI，1.23-1.60）。在白人及“其他”种族类别和向医疗保健提供者披露同性性行为的 MSM 中，诊断变化较大。
自我报告的 MSM 检测和诊断率从 2011 年到 2014 年有所增加。需要加大力度，满足高艾滋病毒风险男男性行为者的年度性传播疾病筛查建议。
